New State Laws Require Insurance to Cover Alzheimer’s Biomarker Tests
In the past two years, the FDA has fully approved two new disease-modifying treatments for Alzheimer’s — and more of these treatments are in the…
In the past two years, the FDA has fully approved two new disease-modifying treatments for Alzheimer’s — and more of these treatments are in the…
After being rejected by EU regulators but approved in the U.S., UK, and several Middle Eastern countries, Alzheimer’s drug Kisunla added a new market:…
Everyone with Alzheimer’s disease has beta-amyloid plaques and tau tangles in their brain. But despite advances across blood tests, cerebrospinal fluid tests, and brain…
This installment of our quarterly Trials Update captures the latest developments in Alzheimer’s and other dementia clinical trials, from January 2025 to present. We’ve…
Fujirebio’s new blood test for Alzheimer’s biomarkers is the first to receive FDA approval, opening the door to Medicare coverage. Here’s what it can…
It can be hard to tell the difference between someone who’s sleeping and someone who’s resting their eyes. But sleeping isn’t just rest —…
Mike Zuendel’s search for his missing cell phone resulted in a trip to the doctor. Forgetting words and misplacing items were clues that something…
At first, scientists had no idea what might cause Alzheimer’s disease and had no underlying protein or pathway to target with treatments. Then came…
Anti-amyloid drugs like Leqembi and Kisunla are among the first FDA-approved treatments for early-stage Alzheimer’s disease. But these breakthroughs come with a tradeoff: Up…
More than a decade ago, Alzheimer’s vaccines appeared in clinical trials — but failed. Now several companies are gearing up to test the next…
A person who struggles with tasks they’ve been doing for years or asks the same question over and over again may be showing the…
People with Down syndrome have a 9/10 chance of developing early-onset Alzheimer’s — a reality tied to genetics. This genetic condition also makes this…
Many people with Alzheimer’s disease first lose neurons in their medial temporal lobe — a region of the brain involved in memory, navigation, emotional…
When ancient Greek soldiers laid their mythical siege upon the city of Troy, they struggled to break through the city’s impenetrable walls. To finally…
Years before any symptoms of Alzheimer’s appear, beta-amyloid and tau proteins misfold, tangle, and aggregate inside the brain. While many people may develop beta-amyloid…